LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170718005298/en/
“Real-world evidence generated from post-market evaluation of devices used in clinical practice will provide important information to support the development of new devices and new uses for currently marketed devices,” said Hanlon. “The sources of these data are advancing quickly – medical devices, point-of-care devices, wearables, apps – creating the promise of rich and precise insights into how patients benefit from these devices as well as respond to new therapies. It is an honor and singular opportunity to serve on the NESTcc Governing Committee, which is bringing together critical stakeholders at this pivotal moment in healthcare. Together, our goal is to increase the responsible use of real-world evidence with an inclusive, patient-centered approach.”
Hanlon is the
“Dr. Hanlon’s expertise in regulatory affairs and clinical development is an important addition to the NEST Coordinating Center’s Governing Committee,” said NESTcc Executive Director
NESTcc’s mission is to support the timely and reliable development of real-world evidence associated with medical devices throughout the total product life cycle. Real-world evidence should be generated in the course of clinical or home care, and will comply with robust methodological standards. With support from the Coordinating Center’s executive director and staff, the Governing Committee will recruit Expert Advisory Working Groups, develop NESTcc bylaws and undertake the development of shared resources through specific demonstration projects.
About LabCorp
LabCorp (NYSE: LH), an
This press release contains forward-looking statements including with respect to estimated 2017 guidance and the impact of various factors on operating and financial results. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace, and adverse actions of governmental and other third-party payers. Actual results could differ materially from those suggested by these forward-looking statements. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. Further information on potential factors that could affect operating and financial results is included in the Company’s Form 10-K for the year ended
View source version on businesswire.com: http://www.businesswire.com/news/home/20170718005298/en/
Source:
LabCorp
Media
Pattie Kushner, +1 336-436-8263
[email protected]
or
Covance Media
Sue Maynard, +1 336-436-8263
[email protected]
or
Investors
Scott Frommer, +1 336-436-5076
[email protected]